Literature DB >> 28509168

Immune thrombocytopenic purpura masking the fatal potential of calciphylaxis in a haemodialysis patient.

Thiam Seong Christopher Lim1, Kah Mean Thong2, Nor Fadhlina Binti Zakaria3, Kalaiselvam Thevandran3, Anim Md Shah3.   

Abstract

Calciphylaxis on the background of immune thrombocytopenic purpura (ITP) has never been described. The pathogenesis of calciphylaxis is complex and not fully understood as yet. ITP has a complex pathogenesis that leads to bleeding or thrombotic events. Although ITP is treatable and reversible, calciphylaxis on the other hand, responds poorly to treatment and carries high mortality and morbidity. We present a case of a 56-year-old lady with end-stage renal disease with ITP, who complained of 1-month history of painful necrotic patches over the thighs. Due to delayed diagnosis, the patient deteriorated and passed away despite aggressive multidisciplinary approach. This case highlights the importance of early recognition of the increased thrombotic risk in an end-stage renal failure patient with poor phosphate control and ITP.

Entities:  

Keywords:  Calcification; Calciphylaxis; End-stage renal failure; Immune thrombocytopenic purpura; Necrosis

Year:  2015        PMID: 28509168      PMCID: PMC5411663          DOI: 10.1007/s13730-015-0194-x

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  10 in total

Review 1.  Evolution of treatment strategies for calciphylaxis.

Authors:  Edward A Ross
Journal:  Am J Nephrol       Date:  2011-10-06       Impact factor: 3.754

Review 2.  Recent progress in understanding the pathogenesis of immune thrombocytopenia.

Authors:  John W Semple; Drew Provan; M Bernadette Garvey; John Freedman
Journal:  Curr Opin Hematol       Date:  2010-11       Impact factor: 3.284

3.  Rapid resolution of calciphylaxis with intravenous sodium thiosulfate and continuous venovenous haemofiltration using low calcium replacement fluid: case report.

Authors:  Giselle Guerra; Ronak C Shah; Edward A Ross
Journal:  Nephrol Dial Transplant       Date:  2005-05-03       Impact factor: 5.992

4.  Calciphylaxis: natural history, risk factor analysis, and outcome.

Authors:  Roger H Weenig; Lindsay D Sewell; Mark D P Davis; James T McCarthy; Mark R Pittelkow
Journal:  J Am Acad Dermatol       Date:  2006-12-01       Impact factor: 11.527

Review 5.  Complement activation on platelets: implications for vascular inflammation and thrombosis.

Authors:  Ellinor I Peerschke; Wei Yin; Berhane Ghebrehiwet
Journal:  Mol Immunol       Date:  2010-06-01       Impact factor: 4.407

6.  Clinical significance of platelet microparticles in autoimmune thrombocytopenias.

Authors:  W Jy; L L Horstman; M Arce; Y S Ahn
Journal:  J Lab Clin Med       Date:  1992-04

7.  Serum fetuin-A levels link inflammation and cardiovascular calcification in hemodialysis patients.

Authors:  Mario Cozzolino; Andrea Galassi; Maria Luisa Biondi; Olivia Turri; Sergio Papagni; Nicola Mongelli; Luigi Civita; Maurizio Gallieni; Diego Brancaccio
Journal:  Am J Nephrol       Date:  2006-09-12       Impact factor: 3.754

8.  Risk factors and mortality associated with calciphylaxis in end-stage renal disease.

Authors:  A R Mazhar; R J Johnson; D Gillen; J C Stivelman; M J Ryan; C L Davis; C O Stehman-Breen
Journal:  Kidney Int       Date:  2001-07       Impact factor: 10.612

9.  The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification.

Authors:  Cora Schafer; Alexander Heiss; Anke Schwarz; Ralf Westenfeld; Markus Ketteler; Jurgen Floege; Werner Muller-Esterl; Thorsten Schinke; Willi Jahnen-Dechent
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

10.  Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodies.

Authors:  Louis M Aledort; Catherine P M Hayward; Mon-Gy Chen; Janet L Nichol; James Bussel
Journal:  Am J Hematol       Date:  2004-07       Impact factor: 10.047

  10 in total
  1 in total

Review 1.  A Review on Secondary Immune Thrombocytopenia in Malaysia.

Authors:  Muhamad Aidil Zahidin; Noor Haslina Mohd Noor; Muhammad Farid Johan; Abu Dzarr Abdullah; Zefarina Zulkafli; Hisham Atan Edinur
Journal:  Healthcare (Basel)       Date:  2021-12-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.